^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    enavatuzumab (PDL192)

    i
    Other names: PDL192, ABT-361
    Associations
    News
    Trials
    Company:
    AbbVie
    Drug class:
    TWEAK inhibitor
    Associations
    News
    Trials